Burden of adverse transplant outcomes in kidney transplant recipients with COVID-19 and invasive fungal infections: a retrospective cohort study
Lucy X. Li(Johns Hopkins University), Nitipong Permpalung(Johns Hopkins University), Kieren A. Marr(Freedom to Live), Sean X. Zhang(Johns Hopkins University), Jiashu Xue(Johns Hopkins University), Teresa Po-Yu Chiang(Johns Hopkins University), John W Baddley(Johns Hopkins University), Christine M. Durand(Johns Hopkins University), Daniel C. Brennan(Johns Hopkins University), Shmuel Shoham(Office of Infectious Diseases), Robin K. Avery(Johns Hopkins University), William A. Werbel(Johns Hopkins University)
Cited by 0
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k